J&J Executive Compensation Details Revealed

Ticker: JNJ · Form: DEF 14A · Filed: 2024-03-13T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, sec-filing, DEF14A

Related Tickers: JNJ

TL;DR

J&J dropped its 2023 exec comp filing - lots of detail on stock awards & pensions for the big bosses.

AI Summary

Johnson & Johnson filed a DEF 14A on March 13, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on equity awards granted to both PEO (Principal Executive Officer) and Non-PEO NEO (Non-Principal Executive Officer Named Executive Officers) members, as well as adjustments and exclusions related to these awards and pension benefits.

Why It Matters

This filing provides transparency into how Johnson & Johnson compensates its top executives, which can influence investor perception and corporate governance.

Risk Assessment

Risk Level: low — This is a routine DEF 14A filing providing information on executive compensation and not indicating any immediate financial distress or significant operational changes.

Key Players & Entities

FAQ

What is the primary purpose of this DEF 14A filing for Johnson & Johnson?

The primary purpose is to provide detailed information regarding the company's executive compensation for the fiscal year ending December 31, 2023, as required by SEC regulations.

When was this DEF 14A filing submitted to the SEC?

This filing was submitted on March 13, 2024.

What period does the executive compensation information in this filing cover?

The filing covers the period of report ending April 25, 2024, with specific compensation details pertaining to the fiscal year ending December 31, 2023.

What types of compensation elements are detailed for PEO and Non-PEO NEOs?

The filing details equity awards granted, equity award adjustments, exclusions of equity awards, and inclusion/exclusion of pension benefits for both PEO and Non-PEO NEOs.

What is Johnson & Johnson's Standard Industrial Classification (SIC) code?

Johnson & Johnson's SIC code is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0000200406-24-000024.txt : 20240313 0000200406-24-000024.hdr.sgml : 20240313 20240313073557 ACCESSION NUMBER: 0000200406-24-000024 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 175 CONFORMED PERIOD OF REPORT: 20240425 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24744580 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 DEF 14A 1 jnj-20240311.htm DEF 14A jnj-20240311 0000200406 DEF 14A FALSE 0000200406 2023-01-02 2023-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0000200406 2022-01-03 2023-01-01 0000200406 2021-01-04 2022-01-02 0000200406 2019-12-30 2021-01-03 0000200406 ecd:PeoMember jnj:ExclusionOfEquityAwardsMember 2023-01-02 2023-12-31 0000200406 ecd:PeoMember jnj:EquityAwardAdjustmentsMember 2023-01-02 2023-12-31 0000200406 ecd:PeoMember jnj:ExclusionOfChangeInPensionBenefitMember 2023-01-02 2023-12-31 0000200406 jnj:InclusionOfPensionBenefitMember ecd:PeoMember 2023-01-02 2023-12-31 0000200406 ecd:NonPeoNeoMember jnj:ExclusionOfEquityAwardsMember 2023-01-02 2023-12-31 0000200406 ecd:NonPeoNeoMember jnj:EquityAwardAdjustmentsMember 2023-01-02 2023-12-31 0000200406 ecd:NonPeoNeoMember jnj:ExclusionOfChangeInPensionBenefitMember 2023-01-02 2023-12-31 0000200406 jnj:InclusionOfPensionBenefitMember ecd:NonPeoNeoMember 2023-01-02 2023-12-31 0000200406 ecd:PeoMember jnj:EquityAwardsGrantedDuringTheYearMember 2023-01-02 2023-12-31 0000200406 jnj:EquityAwardsGrantedInPriorYearsUnvestedMember ecd:PeoMember 2023-01-02 2023-12-31 0000200406 jnj:EquityAwardsGrantedInPriorYearsVestedMember ecd:PeoMember 2023-01-02 2023-12-31 0000200406 ecd:NonPeoNeoMember jnj:EquityAwardsGrantedDuringTheYearMember 2023-01-02 2023-12-31 0000200406 ecd:NonPeoNeoMember jnj:EquityAwardsGrantedInPriorYearsUnvestedMember 2023-01-02 2023-12-31 0000200406 jnj:EquityAwardsGrantedInPriorYearsVestedMember ecd:NonPeoNeoMember 2023-01-02 2023-12-31 0000200406 ecd:PeoMember jnj:InclusionOfPensionServiceCostsMember 2023-01-02 2023-12-31 0000200406 jnj:InclusionOfPriorYearPensionServiceCostMember ecd:PeoMember 2023-01-02 2023-12-31 0000200406 ecd:NonPeoNeoMember jnj:InclusionOfPensionServiceCostsMember 2023-01-02 2023-12-31 0000200406 jnj:InclusionOfPriorYearPensionServiceCostMember ecd:NonPeoNeoMember 2023-01-02 2023-12-31 0000200406 1 2023-01-02 2023-12-31 0000200406 4 2023-01-02 2023-12-31 0000200406 2 2023-01-02 2023-12-31 0000200406 5 2023-01-02 2023-12-31 0000200406 3 2023-01-02 2023-12-31 0000200406 6 2023-01-02 2023-12-31 0000200406 7 2023-01-02 2023-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   ý Filed by a Party other than the Registrant   o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for the Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ý Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under § 240.14a-12 Johnson & Johnson (Name of Registrant as Specified in Its Charter)   (Name of Person(s) Filing Proxy Statement, if Other Than Registrant) Payment of Filing Fee (Check all boxes that apply): ý No fee required. o Fee paid previously with preliminary materials. o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-(6)(i)(4) and 0-11. March 13, 2024 Notice of Annual Meeting & Proxy Statement Time Thursday,

View on Read The Filing